Freda C Lewis Hall Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Freda C Lewis Hall is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SWTX, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2025, when has been sold 24,727 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Freda C Lewis-Hall Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2025	SELL Sale (or disposition) back to the issuer	-	24,727 Reduced 100.0%	0 Common Stock
May 14 2025	BUY Grant, award, or other acquisition	-	10,060 Added 28.92%	24,727 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	-	4,095 Added 21.83%	14,667 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	4,648 Added 30.54%	10,572 Common Stock
May 19 2022	BUY Grant, award, or other acquisition	-	4,818 Added 44.85%	5,924 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	1,106 Added 4.2%	25,227 Common Stock

Also insider at

PFE

PFIZER INC Healthcare

Executive Vice President

EXAS

EXACT SCIENCES CORP Healthcare

Director

ONEM

1Life Healthcare Inc Healthcare

PYXS

Pyxis Oncology, Inc. Healthcare

MURF

Murphy Canyon Acquisition Corp. Financial Services

Director

FCL